Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients

Renal Failure

Volumn 28, Issue 8, 2006, Pages 729-735

  Yakaryilmaz, Fahri ^a,e   Alp Gurbuz, Oguz ^b   Guliter, Sefa ^a   Mert, Ali ^b   Songur, Yildiran ^c   Karakan, Tarkan ^d   Keles, Hatice ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^d GAZI UNIVERSITY   (Turkey)

^e NONE   (Turkey)

Author keywords

Chronic renal failure; Hemodialysis; Occult hepatitis

Indexed keywords

HEPATITIS B CORE ANTIBODY; VIRUS DNA; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; DIAGNOSTIC KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORBIDITY; MORTALITY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CROSS INFECTION; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RENAL DIALYSIS; RNA, VIRAL; TREATMENT OUTCOME; TURKEY;

EID: 33845676938     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220600925602     Document Type: Article

References (55)

1. Zacks SL, Fried MW. Hepatitis B and C renal failure. Infect Dis Clin North Am 2001;15:877-899.
2. Lopez Alcoronho JM, Barril G, Ortiz Movilla N, et al. Prevalence of hepatitis B, hepatitis C, GB virus C/hepatitis G and TT viruses in hemodialysis patients. J Med Virol, 2001;63:103-107.
3. Huang CC. Hepatitis in patients with end-stage renal disease. J Gastroenterol Hepatol 1997;12:236-241.
4. Saha D, Agarwal SK. Hepatitis and HIV infection during hemodialysis. J Indian Med Assoc. 2001;99:194-199.
5. Moreira R, Pinho JRR, Fares J, et al. Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies. Can J Microbiol. 2003;49:503-507.
6. Oesterreicher C, Hammer J, Koch U, et al. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int. 1995;48:1967-1971.
7. Fabrizi F, Poordad F, Martin P. Hepatitis C infection and the patients with end-stage renal disease. Hepatology. 2002;36:3-10.
8. Stevens CE, Alter HJ, Taylor PE, et al. Hepatitis B vaccine in patients receiving hemodialysis: immunogenicity and efficacy. N Engl J Med. 1984;311:496-501.
9. Delarocque-Astagneau E, Baffoy N, Thiers V, et al. Outbreak of hepatitis C virus infection in a hemodialysis unit: Potential transmission by hemodialysis machine? Infect Control Hosp Epidemiol. 2002;23:328-334.
10. Devi KS, Singh NB, Mara J, et al. Seroprevalence of hepatitis B virus and hepatitis C virus among hepatic disorders and injecting drug users in Manipur - a preliminary report. Indian J Med Microbiol. 2004;22:136-137.
11. Mutlu B, Meric M, Willke A. Seroprevalence of hepatitis B and C virus, human immunodeficiency virus and syphilis in the blood donors. Mikrobiyol Bul. 2004;38:445-448.
12. Arankalle VA, Chobe P, Banerjee K. HCV in Pune. J Assoc Physicians India 1992;40:562.
13. Baur P, Daniel V, Pomer S, et al. HCV in kidney recipients: Epidemiology and impact on renal transplantation. Ann Hematol. 1991;62:68-73.
14. Bruguera M, Vidal L, Sanchez-Tapias JM, et al. Incidence and features of liver disease in patients on chronic hemodialysis. J Clin Gastroentrol. 1990;20:5042-5045.
15. Sato S, Fujiyama S, Tanaka M, et al. Co-infection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol. 1994;21:159-166.
16. Pontisso P, Gerotto M, Benvegnu L, et al. Coinfection by hepatitis B virus and hepatitis C virus. Antivir Ther. 1998;3(Suppl. 3):137-142.
17. Sumathy S, Valliammai T, Thyagarajan SP, et al. Prevalence of HCV infection in liver diseases, renal diseases and VBDs in South India. Indian J Med Microbiol. 1993;11:291-297.
18. Cabrerizo M, Bartolome J, De Sequera P, et al. Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen negative hemodialysis patients and staff. J Am Soc Nephrol. 1997;8:1443-1447.
19. Joller-Jemelka HI, Wicki AN, Grob PJ. Detection of HBs antigen in "anti-HBc alone" positive sera. J Hepatol. 1994;21:269-272.
20. Carpenter PA, Huang ML, McDonald GB. Activation of occult hepatitis B from seronegative patient after hematopoietic cell transplant: a cautionary tale. Blood. 2002;99:4245-4246.
21. Besisik F, Karaca C, Akyüz F, et al. Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection. J Hepatol. 2003;38:506-510.
22. Fabrizi F, Martin P, Dixit V, et al. Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients. Am J Nephrol. 1999;19:383-388.
23. Bukh J, Wantzin P, Krogsgaard K, et al. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available anti-body tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group. J Infect Dis. 1993;168:1343-1348.
24. Kjaha MN, Poduri CD, Habeebullah CM. Modified protocol for HBV DNA isolation and detection. Anal Biochem. 2003;314:142-143.
25. Kwok S, Higuchi R. Avoiding false positive with PCR. Nature. 1989;339:237-238.
26. Reddy GA, Dakshinamurty KV, Neeelaprasad P, et al. Prevalence of HBV and HCV dual infection in patients on hemodialysis. Indian J Med Microbiol. 2005;23:41-43.
27. Minuk GY, Sun DF, Greenberg R, et al. Occult hepatitis B virus infection in a North American adult hemodialysis patients population. Hepatology. 2004;40:1072-1077.
28. Mioli VA, Balestra E, Bibiano L, et al. Epidemiology of viral hepatitis in dialysis centers: a national survey. Nephron. 1992;61:278-283.
29. Almawi WY, Qadi AA, Tamim H, et al. Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia. Transplant Procs. 2004;36:1824-1826.
30. Qadi AA, Tamin H, Ameen G, et al. Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods. Am J Infect Control. 2004;32:493-495.
31. Chandra M, Kjaha MN, Hussain MM, et al. Prevalence of hepatitis B and hepatitis C viral infections in Indian patients with chronic renal failure. Intervirology. 2004;47:374-376.
32. Covic A, Iancu L, Apetrei C, et al. Hepatitis virus infection in hemodialysis patients from Moldavia. Nephrol Dial Transplant. 1999;14:40-45.
33. Carletti P, Bibino L, Boggi R, et al. HBV infection in hemodialysis patients: monitoring and prevention. Nephron. 1992;61:269-271.
34. Cendoroglo Neto M, Draibe SA, Silvia AEB, et al. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among hemodialysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant. 1995;10:240-246.
35. Petrosillo N, Scacia F, Puro V, et al. Hepatitis C transmission in dialysis. Nephron. 1993;63:115-121.
36. Raccosta G, Merletti MG, Lisi E, et al. Prevalence of hepatitis in our hemodialysis population. Nephron. 1992;61:300-301.
37. Oguchi H, Miyasaka M, Tokunaga S, et al. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Clin Nephrol. 1992;38:36-43.
38. Fabrizi F, Raffaele L, Bacchini G, et al. Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic hemodialysis patients: a study second generation assays. Neprol Dial Transplant. 1993;8:744-747.
39. Bozdayi G, Rota S, Verdi H, et al. Investigation of the presence of hepatitis C virus infection in hemodialysis patients and determination of HCV genotypes. Mikrobiyol Bul. 2002;36:291-294.
40. Schroter M, Feucht HH, Schafer P, et al. High percentage of seronegative HCV infections in hemodialysis patients: the need for PCR. Intervirology. 1997;40:277-278.
41. Triolo G, Squiccimarro G, Baldi M, et al. Antibodies to HCV in kidney transplantation patients. Int Nephrol. 1992;61:276-277.
42. Umlauft F, Konig R, Weyres KM, et al. HCV infection among long term hemodialysis patients: Detection of HCV RNA in plasma. Hepatology. 1992;16:224A.
43. Hruby Z, Sliwinski J, Molin I, et al. High prevalence of antibodies to hepatitis C virus in three hemodialysis centers in southwestern Poland. Nephrol Dial Transplant. 1993;8:740-743.
44. Akpolat T, Arik N, Gunaydin M, et al. Prevalence of anti-HCV among hemodialysis patients in Turkey: a multicentric study. Nephrol Dial Transplant. 1995;10:479-480.
45. Huraib Al-Rashed R, Aldrees A, Aljerfy M, et al. High prevalence of and risk factors for hepatitis C in hemodialysis patients in Saudi Arabia: a need for new dialysis strategies. Nephrol Dial Transplant. 1995;10:470-474.
46. Meyers CM, Seeff LB, Stehman-Bree CO, et al. Hepatitis C and renal disease: An update. Am J Kidney Dis. 2003;42:631-658.
47. Ihara H, Kato T, Ikeda H, et al. Evaluation of HI method as an anti-HBc screening test. Jpn J Transfus Med. 1990;36:56-61.
48. Haushofer AC, Hauer R, Brunner H, et al. No evidence of hepatitis B virus activity in patients with anti-HBc antibody positivity with or without anti-hepatitis C virus antibody positivity. J Clin Virol. 2004;29:221-223.
49. Xess A, Kumar M, Minz M, et al. Prevalence of hepatitis B and hepatitis C virus co-infection in chronic liver disease. Indian J Pathol Microbiol. 2001;44:253-255.
50. 'Berry N, Chakravati A, Sharma VK, et al. Coinfection with HBV and HIV in HCV infected chronic liver disease. Indian J Med Microbiol. 1998;16:44.
51. Kara IH, Yilmaz ME, Sari Y, et al. Seroprevalence and risk factors of HCV in dialysis patients in a university hemodialysis center of East Anatolia, Turkey. Dial Transplant. 2001;30:748-755.
52. Fabrizi F, Lunghi G, Andrulli S, et al. Influence of hepatitis C virus (HCV) viremia upon serum aminotransferase activity in chronic dialysis patients. Nephrol Dial Transplant. 1997;12:1394-1398.
53. Fabrizi F, Mangano S, Alongi G, et al. Influence of hepatitis B virus viremia upon serum aminotransferase activity in dialysis population. Int J Artif Organs. 2003;26:1048-1055.
54. Fabrizi F, Martin P, Dixit V, et al. Quantitative assessment of HCV load in chronic hemodialysis patients: a cross-sectional survey. Nephron. 1988;80:428-433.
55. Lopes EP, Gouveia EC, Albuquerque AC, et al. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia. J Clin Virol. 2006;35:298-302.